Deep Brain Stimulation Systems Market, By Product Type (Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator), By Application (Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, and Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Globally increasing prevalence of neurological illnesses will increase market demand.

Deep brain stimulation devices are predicted to become increasingly popular due to the rise in neurological disorders worldwide, such as Parkinson's disease, epilepsy, Alzheimer's, depression, dementia, and multiple sclerosis. The Deep Brain Stimulation Market is expanding due to the use of cutting-edge scientific discoveries and new technology in healthcare settings.

For example, the U.S. Centers for Disease Control and Prevention (CDC) anticipated that 5.8 million Americans had Alzheimer's disease in 2020; by 2060, that figure is expected to climb to 14 million. This development is projected to result in a considerable demand for deep brain stimulation approaches.

In addition, the World Health Organization (WHO) estimates that 50 million people worldwide have epilepsy in 2022. Every year, about 5 million individuals worldwide receive an epilepsy diagnosis. In low- to middle-income countries, the annual incidence of epilepsy is estimated to be 139 out of every 100,000 people, while in high-income ones, it is 49 out of every 100,000 people.